Literature DB >> 760828

Starvation-induced changes in secretin-like immunoreactivity of human plasma.

J C Mason, R F Murphy, R W Henry, K D Buchanan.   

Abstract

Levels of secretin-like immunoreactivity in the plasma of 50 starved subjects were measured by radioimmunoassay and rose from 18 +/- 3 (S.E.) pg/ml after 12 h, to 103 +/- 12 pg/ml (P less than 0.005) after 36 h. The assay antibodies were found to be specific for a region of secretin located towards the C-terminal residue. Lactoperoxidase was used to label the secretin with 125I and ionexchange chromatography on SP-Sephadex C-25 was used to purify the labelled product. The plasma immunoreactivity was purified by immunoaffinity chromatography on antibody-Sepharose conjugates and characterised by gel-filtration on Sephadex G-50 calibrated with molecular weight markers. After a 12-h fast, 10-20% of the immunoreactivity had a molecular weight of about 12 000, possibly due to precursors of secretin. Most of the remainder was smaller than secretin with molecular weight of less than 3000. This material comprised over 90% of the plasma immunoreactivity after a 36-h fast and may be due to degradation products.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760828     DOI: 10.1016/0304-4165(79)90394-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Pathophysiology of gastrin and secretin.

Authors:  K D Buchanan; J E Ardill
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

Review 2.  Multiple forms of gastroenteropancreatic hormones.

Authors:  G B Irvine; R F Murphy
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

3.  Terminology for hormone-related polypeptides detected by radioimmunoassay.

Authors:  R F Murphy; K D Buchanan
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

4.  Release of secretin immunoreactivity from the ileum.

Authors:  K G Tranberg; K Tabata; M H Chen; R F Murphy; J E Fischer; S N Joffe
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

5.  Glucagonoma syndrome demonstrating giant duodenal villi.

Authors:  F M Stevens; R W Flanagan; D O'Gorman; K D Buchanan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

6.  The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.

Authors:  O Oktedalen; P K Opstad; O B Schaffalitzky de Muckadell
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1983

7.  The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).

Authors:  Z Gimmon; R F Murphy; M H Chen; C A Nachbauer; J E Fischer; S N Joffe
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

8.  The gastro-entero-pancreatic hormone response to fasting in obesity.

Authors:  W J Andrews; R W Henry; K G Alberti; K D Buchanan
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

9.  Inhibitory mechanism of oxethazaine on release of endogenous secretin and pancreatic response in dogs.

Authors:  Y Yamazaki
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

10.  Lipolytic actions of secretin in mouse adipocytes.

Authors:  Revathi Sekar; Billy K C Chow
Journal:  J Lipid Res       Date:  2013-11-22       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.